Interbody Spine Implants Industry To Grow Fastest in the APAC

The interbody spine implants market size was USD 1,904.8 million in 2021, and it will reach USD 2,471.8 million by 2030, powering at a rate of 2.9% during 2021–2030.

To learn more about this report: https://bit.ly/3C37Dya

The lumbar surgery products had a major share, of over 60%. This is because of the high population suffering from lower back pain, which can be decompressed and steadied by surgeons through cutting-edge technologies and lumbar surgery instruments.

Furthermore, the U.S. dominates the lumbar surgery implants, because of the highly advanced healthcare infra and the increased acceptance of minimally invasive surgeries in the nation.

The metal-based category will dominate the industry, with more than 45% share by 2030, and will have the highest rate in the years to come. 

This can be because of the fact that metal-based implants are extremely used in spine surgeries, because of their diverse properties, for example flexibility, durability, and robustness, making them more popular than others. Furthermore, these implants include metals for example titanium, stainless steel, and tantalum.

The initiation of 3D-printed and custom-fit spine implants is a key trend. 3D printing tech in healthcare facilities has been extensively used, because of its monetary benefits, computation, and ever-snowballing competences that cater to the requirements of the needs of the individual.

Hospitals are the key users of interbody spine implants, as they accomplish spine surgeries in enormous volumes for treating numerous spine disorders. They contribute in excess of half of the share of revenue. It is a well-known facility for the main level of spinal care with a combined method to orthopedics and neuroscience.

Also, the advanced healthcare facilities and knowhow of spine surgeons in hospitals are the major reasons for the expansion of the interbody spine implants market in this category.

North America is the leader of the pack, mostly because of the comparatively higher use of spine implants than the other regions and the high count of spinal fusion and non-fusion surgical procedures.

APAC will grow the fastest at a rate of over 3%, in the years to come. China, Japan, South Korea, India, and Australia  contribute majorly due to the regional industry. This is mainly because of the attendance of a relatively hefty population of patients, increase in consciousness of spinal ailments and options of treatment, enhancements in healthcare infra, and increase in healthcare expenditure.

Also, the increasing ageing population with a high risk of spinal ailments and the growing acceptance of numerous spine surgical procedures will also power the demand for interbody spine implants in the region.

The increasing demand of interbody spine implants has a lot to do with the rising acceptance of MIS surgeries, around the world and increase in the requirement of spinal fusion devices.